• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Cipla Ltd.
    29 Jul 2025
    1574.60
    0.88%
    Stock to buy today: Cipla (1,571) BUY
    Business Line
    Cipla share price can rise to 1,650
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 1114 to 1124 in Jun 2025 qtr.
    Cipla shares rally 6% in 2 days as Q1 results impress; brokerages raise target up to Rs 1,875
    Economic Times | 28 Jul 2025 2 more
    Cipla Share Price Trades Lower Post Q1 Results
    NDTV Profit | 28 Jul 2025
    Cipla Q1 Review: Brokerages Split As HSBC Recommends Buy, Jefferies Maintains Hold
    NDTV Profit | 28 Jul 2025
    logo
    Torrent Pharmaceuticals Ltd.
    28 Jul 2025
    3566.20
    -0.49%
    Torrent Pharmaceuticals Q1 Results: Profit Surges 20%, Revenue Rises
    Torrent Pharmaceuticals Q1 Results: Profit Surges 20%, Revenue Rises
    NDTV Profit
    Margin expands to 32.5% versus 31.6% in the year-ago period.
    Copy LinkShare onShare on Share on Share on
    Torrent Pharmaceuticals Ltd. is trading below its 30 day SMA of 3615.4
    logo
    Alembic Pharmaceuticals Ltd.
    28 Jul 2025
    946.50
    -0.07%
    Alembic Pharmaceuticals gets USFDA nod for generic Carbamazepine tablets
    Business Line
    The approval by the USFDA is for the company's abbreviated new drug application of Carbamazepine extended-release tablets of strengths 100 mg, 200 mg, and 400 mg, it said in a statement
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors decreased from 198 to 192 in Jun 2025 qtr
    logo
    Laurus Labs Ltd.
    28 Jul 2025
    896.05
    0.05%
    Laurus Labs to set up Phama Zone in Andhra Pradesh with 5,630 crore
    Business Line
    Laurus has projected 5630 Crores of investment and to provide employment to 6,350 people in three phases over a period of eight years
    Copy LinkShare onShare on Share on Share on
    Laurus Labs Ltd. has gained 77.24% in the last 1 Year
    logo
    Cipla Ltd.
    27 Jul 2025
    1574.60
    0.88%
    Next US fix could stanch Cipla's Revlimid bleed amid pricing pressure
    Business Standard
    Generics pipeline starts to pulse as Advair, Symbicort, and Abraxane prepare to hit the vein
    Copy LinkShare onShare on Share on Share on
    Deven Choksey released a Hold report for Cipla Ltd. with a price target of 1570.0 on 08 Sep, 2025.
    logo
    RPG Life Sciences Ltd.
    27 Jul 2025
    2380.30
    -0.37%
    RPG Life Sciences' Q1 PAT dips to 26.29 cr
    Business Line
    RPG Life Sciences' Q1 PAT dips, revenue from operations up 2%
    Copy LinkShare onShare on Share on Share on
    RPG Life Sciences Ltd. is trading above its 200 day SMA of 2268.2
    logo
    Aurobindo Pharma Ltd.
    26 Jul 2025
    1094.40
    -1.33%
    Why investors should accumulate Aurobindo Pharma stock
    Business Line
    The drugmaker will enter a phase of modest growth before new ventures become earning drivers
    Copy LinkShare onShare on Share on Share on
    Aurobindo Pharma Ltd. has lost -30.17% in the last 1 Year
    logo
    Torrent Pharmaceuticals Ltd.
    26 Jul 2025
    3566.20
    -0.49%
    Torrent Pharma expands Shelcal brand into adult nutrition supplement powder
    Business Line
    Shelcal Total contains no added sugar, artificial colours and flavours, and is suitable for adults managing their calorie intake
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 913 to 923 in Jun 2025 qtr.
    logo
    Dr. Reddy's Laboratories Ltd.
    26 Jul 2025
    1316.70
    1.04%
    Dr Reddy's Laboratories invests 565 crore in Russian arm
    Business Line
    The transaction was the result of a decision to infuse up to 600 crore in the Russianarm taken by the board of the Hyderabad-based company in November 2024
    Copy LinkShare onShare on Share on Share on
    Dr. Reddy's Laboratories Ltd. is trading above all available SMAs
    logo
    Cipla Ltd.
    25 Jul 2025
    1574.60
    0.88%
    US tariffs will not have debilitating' impact on pharma industry: Cipla global MD & CEO
    Business Line
    Cipla's top executive Umang Vohra said that tariffs on meds pharma sector will not be as high as others, given the importance of medicines in everyone's lives.
    Copy LinkShare onShare on Share on Share on
    Deven Choksey released a Hold report for Cipla Ltd. with a price target of 1570.0 on 08 Sep, 2025.
    Cipla Q1 net profit up 10%, driven by consumer health and generics
    Business Standard | 25 Jul 2025 3 more
    Cipla Q1 PAT rises 10% to 1,298 cr; income at 6,957 cr
    Business Line | 25 Jul 2025
    Cipla Q1 FY26 result: Net profit jumps 10% at 1,298 cr, income rises 4%
    Business Standard | 25 Jul 2025
    Cipla Q1 Results: Profit Rises 10%, Beats Estimates
    NDTV Profit | 25 Jul 2025
    more
    loading
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd